The transcription factor PITX3 is associated with sporadic Parkinson's disease

Neurobiology of Aging

Volumn 30, Issue 5, 2009, Pages 731-738

  Fuchs, Julia ^a   Mueller, Jakob C ^a   Lichtner, Peter ^b   Schulte, Claudia ^a   Munz, Marita ^a   Berg, Daniela ^a   Wüllner, Ullrich ^c   Illig, Thomas ^b   Sharma, Manu ^a   Gasser, Thomas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Association study; Homeoproteins; Midbrain dopaminergic neurons; Neuronal development; Parkinson's disease; PITX3; SNPs

Indexed keywords

TRANSCRIPTION FACTOR OTX2;

ADULT; ARTICLE; CONTROLLED STUDY; ENGRAILED 1 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LMX1B GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PITX3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 62349116838     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.08.014     Document Type: Article

References (53)

1. Alberi L., Sgado P., and Simon H.H. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131 13 (2004) 3229-3236
2. Blanchette M., Kent W.J., Riemer C., Elnitski L., Smit A.F., Roskin K.M., Baertsch R., Rosenbloom K., Clawson H., Green E.D., Haussler D., and Miller W. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res. 14 4 (2004) 708-715
3. Conde L., Vaquerizas J.M., Ferrer-Costa C., de la Cruz X., Orozco M., and Dopazo J. PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes. Nucleic Acids Res. 33 (2005) W501-W505 (Web Server issue)
4. Conde L., Vaquerizas J.M., Santoyo J., Al-Shahrour F., Ruiz-Llorente S., Robledo M., and Dopazo J. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res. 32 (2004) W242-W248 (Web Server issue)
5. Davis C.A., and Joyner A.L. Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. Genes Dev. 2 12B (1988) 1736-1744
6. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 37 11 (2005) 1217-1223
7. Evangelou E., Maraganore D.M., and Ioannidis J.P. Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE 2 (2007) e196
8. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N.Y. Acad. Sci. 991 (2003) 1-14
9. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 Pt 5 (1991) 2283-2301
10. Frantz G.D., Weimann J.M., Levin M.E., and McConnell S.K. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J. Neurosci. 14 10 (1994) 5725-5740
11. Fung H.C., Scholz S., Matarin M., Simon-Sanchez J., Hernandez D., Britton A., Gibbs J.R., Langefeld C., Stiegert M.L., Schymick J., Okun M.S., Mandel R.J., Fernandez H.H., Foote K.D., Rodriguez R.L., Peckham E., De Vrieze F.W., Gwinn-Hardy K., Hardy J.A., and Singleton A. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 5 11 (2006) 911-916
12. Hering R., Petrovic S., Mietz E.M., Holzmann C., Berg D., Bauer P., Woitalla D., Muller T., Berger K., Kruger R., and Riess O. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 62 7 (2004) 1231-1232
13. Hsu S.H., Hsieh-Li H.M., Huang H.Y., Huang P.H., and Li H. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis. Cancer Res. 65 10 (2005) 4041-4050
14. Hudson C., Clements D., Friday R.V., Stott D., and Woodland H.R. Xsox17alpha and -beta mediate endoderm formation in Xenopus. Cell 91 3 (1997) 397-405
15. Hwang D.Y., Fleming S.M., Ardayfio P., Moran-Gates T., Kim H., Tarazi F.I., Chesselet M.F., and Kim K.S. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J. Neurosci. 25 8 (2005) 2132-2137
16. Illig T., Bongardt F., Schopfer A., Holle R., Muller S., Rathmann W., Koenig W., Meisinger C., Wichmann H.E., and Kolb H. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52 11 (2003) 2861-2864
17. Kleinjan D.A., and van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76 1 (2005) 8-32
18. Krauss S., Maden M., Holder N., and Wilson S.W. Zebrafish pax[b] is involved in the formation of the midbrain-hindbrain boundary. Nature 360 6399 (1992) 87-89
19. Le W.D., Xu P., Jankovic J., Jiang H., Appel S.H., Smith R.G., and Vassilatis D.K. Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 33 1 (2003) 85-89
20. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., and Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296 6 (2006) 661-670
21. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., and Ballinger D.G. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77 5 (2005) 685-693
22. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., Nagai Y., Oka A., Inoko H., Fukae J., Saito Y., Sawabe M., Murayama S., Yamamoto M., Hattori N., Murata M., and Toda T. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum. Mol. Genet. 15 7 (2006) 1151-1158
23. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., Berg D., Wullner U., Meitinger T., and Gasser T. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann. Neurol. 57 4 (2005) 535-541
24. Mueller J.C., Lohmussaar E., Magi R., Remm M., Bettecken T., Lichtner P., Biskup S., Illig T., Pfeufer A., Luedemann J., Schreiber S., Pramstaller P., Pichler I., Romeo G., Gaddi A., Testa A., Wichmann H.E., Metspalu A., and Meitinger T. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am. J. Hum. Genet. 76 3 (2005) 387-398
25. Niu T.K., Pfeifer A.C., Lippincott-Schwartz J., and Jackson C.L. Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol. Biol. Cell 16 3 (2005) 1213-1222
26. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., and Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 100 7 (2003) 4245-4250
27. Prakash N., and Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell Mol. Life Sci. 63 2 (2006) 187-206
28. Puelles E., Acampora D., Lacroix E., Signore M., Annino A., Tuorto F., Filosa S., Corte G., Wurst W., Ang S.L., and Simeone A. Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain. Nat. Neurosci. 6 5 (2003) 453-460
29. Rieger D.K., Reichenberger E., McLean W., Sidow A., and Olsen B.R. A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice. Genomics 72 1 (2001) 61-72
30. Sandelin A., Wasserman W.W., and Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32 (2004) W249-W252 (Web Server issue)
31. Semina E.V., Ferrell R.E., Mintz-Hittner H.A., Bitoun P., Alward W.L., Reiter R.S., Funkhauser C., Daack-Hirsch S., and Murray J.C. A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat. Genet. 19 2 (1998) 167-170
32. Semina E.V., Murray J.C., Reiter R., Hrstka R.F., and Graw J. Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum. Mol. Genet. 9 11 (2000) 1575-1585
33. Siepel A., Bejerano G., Pedersen J.S., Hinrichs A.S., Hou M., Rosenbloom K., Clawson H., Spieth J., Hillier L.W., Richards S., Weinstock G.M., Wilson R.K., Gibbs R.A., Kent W.J., Miller W., and Haussler D. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15 8 (2005) 1034-1050
34. Simeone A. Genetic control of dopaminergic neuron differentiation. Trends Neurosci. 28 2 (2005) 62-65 discussion 5-6
35. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21 9 (2001) 3126-3134
36. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., and Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3 4 (2000) 337-341
37. Smidt M.P., Smits S.M., Bouwmeester H., Hamers F.P., van der Linden A.J., Hellemons A.J., Graw J., and Burbach J.P. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131 5 (2004) 1145-1155
38. Smidt M.P., van Schaick H.S., Lanctot C., Tremblay J.J., Cox J.J., van der Kleij A.A., Wolterink G., Drouin J., and Burbach J.P. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 94 24 (1997) 13305-13310
39. Smits S.M., Ponnio T., Conneely O.M., Burbach J.P., and Smidt M.P. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18 7 (2003) 1731-1738
40. Sohn J., Natale J., Chew L.J., Belachew S., Cheng Y., Aguirre A., Lytle J., Nait-Oumesmar B., Kerninon C., Kanai-Azuma M., Kanai Y., and Gallo V. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J. Neurosci. 26 38 (2006) 9722-9735
41. Song D.L., Chalepakis G., Gruss P., and Joyner A.L. Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. Development 122 2 (1996) 627-635
42. Sonnier L., Le Pen G., Hartmann A., Bizot J.C., Trovero F., Krebs M.O., and Prochiantz A. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J. Neurosci. 27 5 (2007) 1063-1071
43. Steffens M., Lamina C., Illig T., Bettecken T., Vogler R., Entz P., Suk E.K., Toliat M.R., Klopp N., Caliebe A., Konig I.R., Kohler K., Ludemann J., Lacava A.D., Fimmers R., Lichtner P., Ziegler A., Wolf A., Krawczak M., Nurnberg P., Hampe J., Schreiber S., Meitinger T., Wichmann H.E., Roeder K., Wienker T.F., and Baur M.P. SNP-based analysis of genetic substructure in the German population. Hum. Hered. 62 1 (2006) 20-29
44. Tan E.K., Chung H., Zhao Y., Shen H., Chandran V.R., Tan C., Teoh M.L., Yih Y., Pavanni R., and Wong M.C. Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Neurosci. Lett. 347 3 (2003) 139-142
45. Torlakovic E., Slipicevic A., Robinson C., DeCoteau J.F., Alfsen G.C., Vyberg M., Chibbar R., and Florenes V.A. Pax-5 expression in nonhematopoietic tissues. Am. J. Clin. Pathol. 126 5 (2006) 798-804
46. Urbanek P., Wang Z.Q., Fetka I., Wagner E.F., and Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79 5 (1994) 901-912
47. van den Munckhof P., Luk K.C., Ste-Marie L., Montgomery J., Blanchet P.J., Sadikot A.F., and Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130 11 (2003) 2535-2542
48. Varnum D.S., and Stevens L.C. Aphakia, a new mutation in the mouse. J. Hered. 59 2 (1968) 147-150
49. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., and Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253 2 (1999) 737-746
50. Westerberg R., Mansson J.E., Golozoubova V., Shabalina I.G., Backlund E.C., Tvrdik P., Retterstol K., Capecchi M.R., and Jacobsson A. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J. Biol. Chem. 281 8 (2006) 4958-4968
51. Xu P.Y., Liang R., Jankovic J., Hunter C., Zeng Y.X., Ashizawa T., Lai D., and Le W.D. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 58 6 (2002) 881-884
52. Zhao X., Claude A., Chun J., Shields D.J., Presley J.F., and Melancon P. GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic. J. Cell Sci. 119 Pt 18 (2006) 3743-3753
53. Zheng K., Heydari B., and Simon D.K. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch. Neurol. 60 5 (2003) 722-725